Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
Notified -
Globe Newswire27-05-2025, 19:30
NSERC awards funding for General Fusion LM26 diagnostic system 13-11-2024, 21:00